Loading…

Subinhibitory concentrations of antibiotics affect development and parameters of Helicobacter pylori biofilm

causes chronic gastric diseases in nearly 50% of people around the world. It is suggested that biofilm formation has a pronounced effect on the dynamic resistance spread and recurrence of these infections. To mimic the scenario of therapeutic ineffectiveness, we investigated the impact of sub-minima...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2024-10, Vol.15, p.1477317
Main Authors: Krzyżek, Paweł, Migdał, Paweł, Tusiewicz, Kaja, Zawadzki, Marcin, Szpot, Paweł
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:causes chronic gastric diseases in nearly 50% of people around the world. It is suggested that biofilm formation has a pronounced effect on the dynamic resistance spread and recurrence of these infections. To mimic the scenario of therapeutic ineffectiveness, we investigated the impact of sub-minimal inhibitory concentrations (sub-MICs) of antibiotics on the development and parameters of biofilms produced by clinical strains. We observed that constant exposure of planktonic forms to metronidazole or levofloxacin stimulated the speed of autoaggregation and the amount of extracellular matrix, resulting in increased dimensions of the developed biofilms. Contrary to this, continuous exposure to clarithromycin negatively affected a number of biofilm-related reactions and led to the biofilm-weakening effect. Through assessing the membrane fatty acid profiles of antibiotic-exposed cells, we confirmed that metronidazole and levofloxacin induced a biofilm-like phenotype, while clarithromycin kept bacteria in a planktonic form. Our results suggest that sub-MICs of antibiotics affect the biochemical and biophysical properties of the developing biofilm of strains and may impact the effectiveness of antibiotic treatment.
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2024.1477317